MultiFunctional Imaging
Private Company
Funding information not available
Overview
MultiFunctional Imaging is a specialized medical software company commercializing patented technologies for multi-tracer positron emission tomography (PET) imaging. Its lead product, mfiVerse™, is FDA 510(k) cleared for performing rest and stress myocardial perfusion imaging in a single scan, directly addressing workflow inefficiencies in cardiac PET. The company also offers mfEVolve™ for research applications, positioning itself at the intersection of advanced imaging analytics, clinical diagnostics, and medical device software. With deep academic roots and an experienced leadership team, MFI aims to translate complex imaging research into practical clinical and research tools.
Technology Platform
Proprietary software algorithms for multi-tracer and multi-state PET imaging, enabling the quantification of multiple physiological parameters (e.g., rest and stress perfusion, tumor phenotypes) from a single, dynamic scan. Comprises MFI–Cardiac, MFI–Oncology, and MFI–Kinetic technology families.
Opportunities
Risk Factors
Competitive Landscape
MFI competes in the medical imaging software space, potentially against large OEMs like Siemens, GE, and Philips who offer proprietary scanner software. It also faces competition from other specialized cardiac analysis software vendors. Its primary competitive advantage is its patented, FDA-cleared technology for single-scan dual-state imaging, a niche not broadly addressed by incumbents.